| A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis JM Bathon, RW Martin, RM Fleischmann, JR Tesser, MH Schiff, ... New England Journal of Medicine 343 (22), 1586-1593, 2000 | 2409 | 2000 |
| Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. P Clements, P Lachenbruch, J Siebold, B White, S Weiner, R Martin, ... The Journal of rheumatology 22 (7), 1281-1285, 1995 | 1077 | 1995 |
| Etanercept versus methotrexate in patients with early rheumatoid arthritis: two‐year radiographic and clinical outcomes MC Genovese, JM Bathon, RW Martin, RM Fleischmann, JR Tesser, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2002 | 991 | 2002 |
| Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. PJ Clements, PA Lachenbruch, JR Seibold, B Zee, VD Steen, P Brennan, ... The Journal of rheumatology 20 (11), 1892-1896, 1993 | 579 | 1993 |
| Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial D Khanna, CJF Lin, DE Furst, J Goldin, G Kim, M Kuwana, Y Allanore, ... The Lancet Respiratory Medicine 8 (10), 963-974, 2020 | 442 | 2020 |
| High‐dose versus low‐dose D‐penicillamine in early diffuse systemic sclerosis: analysis of a two‐year, double‐blind, randomized, controlled clinical trial PJ Clements, DE Furst, WK Wong, M Mayes, B White, F Wigley, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1999 | 438 | 1999 |
| Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon PA Merkel, K Herlyn, RW Martin, JJ Anderson, MD Mayes, P Bell, JH Korn, ... Arthritis & Rheumatism 46 (9), 2410-2420, 2002 | 407 | 2002 |
| Ambient and laboratory evaluation of a low-cost particulate matter sensor KE Kelly, J Whitaker, A Petty, C Widmer, A Dybwad, D Sleeth, R Martin, ... Environmental pollution 221, 491-500, 2017 | 405 | 2017 |
| Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high‐dose versus low‐dose penicillamine trial PJ Clements, EL Hurwitz, WK Wong, JR Seibold, M Mayes, B White, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2000 | 395 | 2000 |
| Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis. LW Moreland, SB Cohen, SW Baumgartner, EA Tindall, K Bulpitt, R Martin, ... The Journal of Rheumatology 28 (6), 1238-1244, 2001 | 289 | 2001 |
| Predictors and outcomes of scleroderma renal crisis: the high‐dose versus low‐dose d‐penicillamine in early diffuse systemic sclerosis trial PJ DeMarco, MH Weisman, JR Seibold, DE Furst, WK Wong, EL Hurwitz, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2002 | 279 | 2002 |
| Health-related quality of life in early rheumatoid arthritis: impact of disease and treatment response M Kosinski, SC Kujawski, R Martin, LA Wanke, MC Buatti, JE Ware, ... American Journal of Managed Care 8 (3), 231-242, 2002 | 237 | 2002 |
| Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo‐controlled, double‐blind study FM Wigley, JH Korn, ME Csuka, TA Medsger Jr, NF Rothfield, M Ellman, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1998 | 235 | 1998 |
| The Clinical Spectrum of the Eosinophilia-Myalgia Syndrome Associated with L-Tryptophan Ingestion: Clinical Features in 20 Patients and Aspects of Pathophysiology RW Martin, J Duffy, AG Engel, JT Lie, CA Bowles, TP Moyer, GJ Gleich Ann Intern Med 113 (2), 124-134, 1990 | 208 | 1990 |
| Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept. PJ Mease, CT Ritchlin, RW Martin, AB Gottlieb, SW Baumgartner, ... The Journal of Rheumatology 31 (7), 1356-1361, 2004 | 205 | 2004 |
| Longterm safety, efficacy, and radiographic outcome with etanercept treatment in patients with early rheumatoid arthritis. MC Genovese, JM Bathon, RM Fleischmann, LW Moreland, RW Martin, ... The Journal of rheumatology 32 (7), 1232-1242, 2005 | 181 | 2005 |
| Etanercept treatment in adults with established rheumatoid arthritis: 7 years of clinical experience. LW Moreland, ME Weinblatt, EC Keystone, JM Kremer, RW Martin, ... The Journal of rheumatology 33 (5), 854-861, 2006 | 165 | 2006 |
| Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study D Khanna, DE Furst, RD Hays, GS Park, WK Wong, JR Seibold, ... Annals of the rheumatic diseases 65 (10), 1325-1329, 2006 | 164 | 2006 |
| Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis PJ Clements, WK Wong, E L. Hurwitz, DE Furst, M Mayes, B White, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1999 | 145 | 1999 |
| MQX‐503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial L Chung, L Shapiro, D Fiorentino, M Baron, J Shanahan, S Sule, V Hsu, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2009 | 138 | 2009 |
